在非细菌性CP/CPPS中对隐藏的细菌参与和抗生素疗效的前性评估:解决尚未探索的治疗方法
Hiroyuki Kitano1, Hiroki Ohge2, Kayoko Tadera3
1Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan. tanokin@hiroshima-u.ac.jp.
World journal of urology
|September 15, 2025
概括
这项研究表明,一些以前被认为非细菌的慢性前列腺炎/慢性骨盆疼痛综合征 (CP/CPPS) 病例中存在细菌的参与. 抗生素治疗显示出临床有效性,即使与非病原性细菌.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 微生物学 微生物学
- 传染性疾病 传染性疾病
背景情况:
- 慢性前列腺炎/慢性盆腔疼痛综合征 (CP/CPPS) 通常被归类为非细菌性,这给诊断和治疗带来了挑战.
- 在CP/CPPS中识别潜在的细菌病原体对于有针对性的治疗策略至关重要.
研究的目的:
- 为了调查潜在的细菌参与CP/CPPS病例被归类为非细菌.
- 评估对这些已识别的细菌病原体抗生素治疗的临床疗效.
主要方法:
- 根据前列腺按摩前后尿液分析,患者被分为CP/CPPS类别IIIb和细菌性前列腺炎子组.
- 两组之间的治疗结果进行了比较,并根据尿病原体或非尿病原体检测进一步分析了细菌亚组的反应.
主要成果:
- 与IIIb组相比,细菌性前列腺炎小组在疼痛和生活质量方面表现出显著的改善.
- 在细菌亚组中,尿路病原体阳性和非尿路病原体阳性患者都经历了疼痛减轻,非尿路病原体组的改善更大.
结论:
- 一些被诊断为CP/CPPS类别IIIb的患者可能有未被诊断的细菌参与.
- 抗生素治疗对于CP/CPPS可能是有效的,包括涉及非病原性细菌的病例.
相关概念视频
Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
Urine Studies II: Urine Culture and Sensitivity Test
879
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
879
Antibiotic Selection
59.4K
Overview
59.4K


